Taiwan FDA registration 77af61bdda9f1b3d8b879d23c0790685
HemosIL Liquid Heparin
TW: 希摩西爾液態肝素試劑
Taiwan·Risk Class 2·MD·INSTRUMENTATION LABORATORY CO.·Registered Sep 10, 2013 – Sep 10, 2023ExpiredRegistration details
- Analysis ID
- 77af61bdda9f1b3d8b879d23c0790685
- License Form
- Ministry of Health Medical Device Import No. 025280
- Customs Code
- DHA05602528009
Company information
- Manufacturer
- INSTRUMENTATION LABORATORY CO.
- Manufacturer Country
- United States
- Authorized Representative
- Werfen Taiwan Limited
Product details
- Intended Use
- This product uses IL blood coagulation instrument system (ACL TOP series, ACL ELITE/ELITE PRO/8/9/10000, and ACL Futura/ACL Advance) to quantitatively measure unfractionheparin (UFH) and low molecular weight heparin in human citrate acidated plasma by automated colorimetric quantitation, LMWH).
- Product Type (Level 1)
- B Hematology and pathology devices
- Product Type (Level 2)
- B7525 Heparin analysis
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Sep 10, 2013
- Expiry Date
- Sep 10, 2023
About this record
Access comprehensive regulatory information for HemosIL Liquid Heparin in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 77af61bdda9f1b3d8b879d23c0790685 and manufactured by INSTRUMENTATION LABORATORY CO.. The authorized representative in Taiwan is Werfen Taiwan Limited.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices